What to Expect from Pharmacovigilance Services in 2027

Meet Navitas Life Sciences at Pharmacovigilance India 2026 As the pharmaceutical industry embraces artificial intelligence, real-world evidence and in...

Continue reading
  17 Hits

PK Studies in Patients: Choosing the Right Study Design for Faster Drug Development

Drug development begins with one fundamental question: How does the body handle a drug and how does the drug affect the body?The answer comes from pha...

Continue reading
  28 Hits

Data Science: The Competitive Advantage in Modern Drug Development

Boutique by Design. Outcome-focused by Model. As clinical trials become increasingly complex, sponsors need more than functional support, they need ex...

Continue reading
  63 Hits

What Contract Research Partners Are Best for Running Decentralized or Hybrid Clinical Trials?

How biotech companies can identify the right CRO partner to accelerate patient recruitment, improve trial quality, reduce operational burden and deliv...

Continue reading
  114 Hits

Why Global Pharma Needs Concierge Governance for Controlled Regulatory Data

Pharmaceutical organizations are facing a new challenge that goes beyond clinical development, pharmacovigilance and regulatory submissions: controlli...

Continue reading
  215 Hits

How Pharmacovigilance Consulting Services Build Scalable PV Systems

Bringing a new therapy to market is one of the most significant milestones in a pharmaceutical or biotechnology company's journey. Yet, while organiza...

Continue reading
  127 Hits

Full-Service CRO vs FSP: Which Model Is Right for Your Clinical Development Program?

Biotech and pharma companies face increasing pressure to accelerate timelines, manage costs, cater to regulatory changes and maintain quality across g...

Continue reading
  180 Hits

How Small Biotechs Can Operate Like Big Pharma Without Big Pharma Budgets

Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile...

Continue reading
  521 Hits

25 Years of Navitas Industry Networks Through 25 Voices of Peer Leadership

25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceuti...

Continue reading
  173 Hits

Advancing Parkinson’s Disease Research Through Smarter Clinical Trial Partnerships

How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’...

Continue reading
  155 Hits

Why End-to-End Clinical Trial Solutions Are Becoming Critical for Global Drug Development

How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the ...

Continue reading
  219 Hits

5 Mistakes Biotech Companies Make When Choosing a CRO

Selecting the right clinical research organization (CRO) can determine the success or failure of a biotech company’s clinical program. With inc...

Continue reading
  247 Hits

R Programming in the Age of AI: A Pharmaverse Webinar

The conversation around R programming has fundamentally changed. What was once viewed as a niche statistical language, largely confined to academia, h...

Continue reading
  318 Hits

SAHPRA Update: pharmaREADY® for eCTD Submissions

SAHPRA Application ID Update 2025: Impact on eCTD Submission and eCTD Publishing The South African Health Products Regulatory Authority (SAHPRA) relea...

Continue reading
  233 Hits

The History of Navitas Networks: From a simple platform to the 25th Anniversary

In 2001, a small group of life sciences leaders came together with a simple but unconventional idea, to create a space where industry peers could coll...

Continue reading
  314 Hits

From Clinical Safety to Commercial Readiness: A Pharmacovigilance-in-a-Box Solution

Organizations approaching regulatory approval and commercialization face a rapid expansion in pharmacovigilance requirements, moving from development-...

Continue reading
  359 Hits

How Navitas’ Ophthalmology Clinical Trials Are Solving Biotech Challenges

Biotech Innovation Meets Clinical Trial Excellence Biotech innovation is advancing rapidly but translating breakthroughs into approved therapies remai...

Continue reading
  298 Hits

The Data Backbone of Hybrid Clinical Trials

Turning Regulatory Complexity into Strategic Advantage Hybrid and decentralized models are becoming the default architecture for modern clinical devel...

Continue reading
  182 Hits

Real world Evidence Solutions for Foundations

Real-world evidence (RWE) is emerging as a cornerstone of modern clinical development and regulatory strategy for patient-centric innovation. How is r...

Continue reading
  274 Hits

Navitas Earns EcoVadis Award for Second Year in a Row

Navitas has been awarded the EcoVadis Bronze Medal for the second consecutive year, showcasing the organization’s commitment to Environmental, ...

Continue reading
  250 Hits

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us